Literature DB >> 6025444

Effect of diethylaminoethyl dextran on the growth of Mycoplasma in agar.

N M Tauraso.   

Abstract

The growth of certain strains of Mycoplasma is inhibited by substances present in commercial agar preparations. The addition of diethylaminoethyl (DEAE) dextran (10 mg per 100 ml) to agar media appears to enhance the growth of some strains. Of eight strains initially tested, the presence of DEAE dextran grossly enhanced the growth of three strains. One strain appeared not to be affected, and a clearly enhancing effect was not evident with four strains. Quantitative studies revealed that growth enhancement varied from 10 colony-forming units (CFU) for M. hominis type II (strain Campo) to 10(3.3) CFU for M. pulmonis (strain 880). The growth-enhancing effect is probably due to the ability of DEAE dextran to bind the sulfated polysaccharide moieties in agar and not to the DEAE dextran, per se.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6025444      PMCID: PMC276649          DOI: 10.1128/jb.93.5.1559-1564.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  13 in total

1.  SOME FACTORS AFFECTING PLAQUE SIZE OF WESTERN EQUINE ENCEPHALOMYELITIS VIRUS.

Authors:  L N BROWN; R A PACKER
Journal:  Am J Vet Res       Date:  1964-03       Impact factor: 1.156

2.  STUDIES OF THREE VARIANTS OF MENGO ENCEPHALOMYELITIS VIRUS. II. INHIBITION OF INTERACTION WITH L CELLS BY AN AGAR INHIBITOR AND BY PROTAMINE.

Authors:  J S COLTER; M A DAVIES; J B CAMPBELL
Journal:  Virology       Date:  1964-12       Impact factor: 3.616

3.  Plaque mutants of WEE virus.

Authors:  R N USHIJIMA; D W HILL; G H DOLANA; L P GEBHARDT
Journal:  Virology       Date:  1962-06       Impact factor: 3.616

4.  Inhibition of infectious and hemagglutinating properties of type 2 dengue virus by aqueous Agar extracts.

Authors:  I T SCHULZE; R W SCHLESINGER
Journal:  Virology       Date:  1963-01       Impact factor: 3.616

5.  A medium free of agar, serum and peptone for plaque assay of herpes simplex virus.

Authors:  A A TYTELL; R E NEUMAN
Journal:  Proc Soc Exp Biol Med       Date:  1963-06

6.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

7.  Alteration plaque morphology of EMC virus with polycations.

Authors:  H LIEBHABER; K K TAKEMOTO
Journal:  Virology       Date:  1961-08       Impact factor: 3.616

8.  Isolation and identification of PPLO.

Authors:  S MADOFF
Journal:  Ann N Y Acad Sci       Date:  1960-01-15       Impact factor: 5.691

9.  The inhibitory action of agar on certain strains of pleuropneumonia-like organisms.

Authors:  R J LYNN; H E MORTON
Journal:  Appl Microbiol       Date:  1956-11

10.  Mode of Action of an Inhibitor from Agar on Growth and Hemagglutination of Group A Arboviruses.

Authors:  J I Colón; J B Idoine; O M Brand; R D Costlow
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

View more
  4 in total

1.  Agarose soy casein digest medium for replacement of blood agar for potency determinations of live Pasteurella vaccines.

Authors:  P A Rebers; G G Christianson; G A Laird; J Symanowski
Journal:  Appl Environ Microbiol       Date:  1989-01       Impact factor: 4.792

2.  In vitro susceptibility of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis to fifty-one antimicrobial agents.

Authors:  P P Williams
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

3.  Intracage ammonia promotes growth of Mycoplasma pulmonis in the respiratory tract of rats.

Authors:  T R Schoeb; M K Davidson; J R Lindsey
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  Selective medium for culture of Mycoplasma hyopneumoniae.

Authors:  Beth S Cook; Jessica G Beddow; Lucía Manso-Silván; Gareth A Maglennon; Andrew N Rycroft
Journal:  Vet Microbiol       Date:  2016-09-30       Impact factor: 3.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.